2020
DOI: 10.1016/j.isci.2020.101446
|View full text |Cite
|
Sign up to set email alerts
|

Glyburide Regulates UCP1 Expression in Adipocytes Independent of KATP Channel Blockade

Abstract: Summary Identification of safe and effective compounds to increase or activate UCP1 expression in brown or white adipocytes remains a potent therapeutic strategy to combat obesity. Here we reported that, glyburide, one of the FDA-approved drugs currently used to treat type 2 diabetes, can significantly enhance UCP1 expression in both brown and white adipocytes. Glyburide-fed mice exhibited a clear resistance to high-fat diet-induced obesity, reduced blood triglyceride level, and increased UCP1 expre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 37 publications
0
8
0
Order By: Relevance
“…Eight drugs were chosen, including two antidiabetic drugs (Met and Gli), three antioxidants (NAC, Xan, and Ant), two anti-inflammatory drugs (Chl and Ofl), and Pol, an inhibitor of advanced glycosylation end products (AGEs) . The exact antidiabetic mechanisms of Met and Gli have not been fully disclosed, but these two drugs have been considered to undergo different pathways. , Antioxidants and anti-inflammatory drugs were employed because of the elevated oxidative stress during DC pathogenesis, as well as the tight inflammation association . Meanwhile, AGEs are generated from nonenzymatic glycation between proteins and excess glucose or pentose and are regarded as taking charge of diabetic vascular complications .…”
Section: Resultsmentioning
confidence: 99%
“…Eight drugs were chosen, including two antidiabetic drugs (Met and Gli), three antioxidants (NAC, Xan, and Ant), two anti-inflammatory drugs (Chl and Ofl), and Pol, an inhibitor of advanced glycosylation end products (AGEs) . The exact antidiabetic mechanisms of Met and Gli have not been fully disclosed, but these two drugs have been considered to undergo different pathways. , Antioxidants and anti-inflammatory drugs were employed because of the elevated oxidative stress during DC pathogenesis, as well as the tight inflammation association . Meanwhile, AGEs are generated from nonenzymatic glycation between proteins and excess glucose or pentose and are regarded as taking charge of diabetic vascular complications .…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, thermogenesis could also explain the effects derived from M. alba L. administration. Specifically, UCP1 protein is considered a major regulator of adipose energy expenditure and metabolic homeostasis through thermogenesis activation [ 53 , 54 ]. UCP1 uncouples the proton motive force generated in the mitochondria from ATP production to produce heat, thus increasing the energy expenditure.…”
Section: Discussionmentioning
confidence: 99%
“…The white preadipocytes provided by Dr. Qiurong Ding, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences [ 23 ], Cultured in a primary medium composed of high glucose DMEM, 20 % FBS and 1 % penicillin / Streptomycin at 37 °C in 5 % CO2. The differentiation induction medium was prepared as follows: 10 % FBS + DMEM, 5 µg/mL insulin, 1000nM dexamethasone, 0.5mM isobutyl-1-methylxanthine (IBMX) and 1µM rosiglitazone.…”
Section: Methodsmentioning
confidence: 99%